https://med.bayer.ca/article/test-article 2025-03-17T17:46:37+00:00 0.5 https://med.bayer.ca/article/mode-action-finerenone 2025-03-17T11:37:46+00:00 0.5 https://med.bayer.ca/fr/article/mode-daction-de-la-finerenone 2025-03-17T11:37:46+00:00 0.5 https://med.bayer.ca/article/fidelio-dkd-design 2025-03-17T11:39:15+00:00 0.5 https://med.bayer.ca/fr/article/plan-de-letude-fidelio-dkd 2025-03-17T11:39:15+00:00 0.5 https://med.bayer.ca/article/figaro-dkd-design 2025-03-17T11:32:15+00:00 0.5 https://med.bayer.ca/fr/article/plan-de-letude-figaro-dkd 2025-03-17T11:32:15+00:00 0.5 https://med.bayer.ca/article/fidelity-dkd-design 2025-03-17T11:33:55+00:00 0.5 https://med.bayer.ca/fr/article/plan-de-letude-fidelity-dkd 2025-03-17T11:33:55+00:00 0.5 https://med.bayer.ca/article/fine-arts-design 2025-03-17T11:35:16+00:00 0.5 https://med.bayer.ca/fr/article/plan-de-letude-fine-arts 2025-03-17T11:35:16+00:00 0.5 https://med.bayer.ca/article/advances-intrauterine-contraception-mirenas-thirty-year-legacy 2025-03-17T17:53:42+00:00 0.5 https://med.bayer.ca/fr/article/avancees-en-contraception-intra-uterine-30-ans-dhistoire-de-mirena 2025-03-17T17:53:42+00:00 0.5 https://med.bayer.ca/article/test-magazine-page 2025-05-06T13:29:40+00:00 0.5 https://med.bayer.ca/article/test-image-info-block-en 2025-06-03T12:35:21+00:00 0.5 https://med.bayer.ca/fr/article/test-image-info-block-fr 2025-06-03T12:35:21+00:00 0.5 https://med.bayer.ca/node/1386 2025-07-28T18:48:07+00:00 0.5 https://med.bayer.ca/article/submit-question 2026-01-22T13:43:37+00:00 0.5 https://med.bayer.ca/fr/article/soumettre-une-question 2026-01-22T13:43:37+00:00 0.5 https://med.bayer.ca/article/upcoming-events 2025-08-13T18:35:58+00:00 0.5 https://med.bayer.ca/article/test-article-hero 2025-10-01T12:40:13+00:00 0.5 https://med.bayer.ca/article/english-nephropathie-chronique-et-diabete-perspectives-modifiant-les-pratiques-provenant 2025-11-03T19:37:16+00:00 0.5 https://med.bayer.ca/article/test-mep-0 2026-02-26T20:26:45+00:00 0.5 https://med.bayer.ca/cardiorenal_upcoming_events 2026-03-19T15:07:07+00:00 0.5 https://med.bayer.ca/article/mra-differentiation 2026-03-06T16:54:13+00:00 0.5 https://med.bayer.ca/article/benefit-across-ejection-fraction-spectrum 2026-03-06T16:59:13+00:00 0.5 https://med.bayer.ca/article/progression-remission-changing-narrative-around-chronic-kidney-disease-onqc 2026-03-11T20:12:20+00:00 0.5 https://med.bayer.ca/article/progression-remission-changing-narrative-around-chronic-kidney-disease-bc 2026-03-11T20:13:01+00:00 0.5 https://med.bayer.ca/article/progression-remission-changing-narrative-around-chronic-kidney-disease-abskmn 2026-03-11T20:13:27+00:00 0.5 https://med.bayer.ca/article/chronic-heart-failure-and-its-role-cardio-renal-axis-current-perspectives 2026-03-12T13:20:40+00:00 0.5 https://med.bayer.ca/article/integrating-current-guidelines-heart-failure-and-ckd-daily-clinical-care-new-perspectives 2026-03-12T13:19:51+00:00 0.5 https://med.bayer.ca/article/accelerating-early-diagnosis-chronic-heart-failure-and-chronic-kidney-disease-clearing-path 2026-03-12T13:22:28+00:00 0.5 https://med.bayer.ca/article/redefining-heart-failure-management-emerging-role-nonsteroidal-mras-light-finearts-hf 2026-03-12T13:35:41+00:00 0.5 https://med.bayer.ca/cardiorenal_past_events 2026-03-19T15:06:12+00:00 0.5 https://med.bayer.ca/article/cardio-renal-learning-events 2026-04-20T15:10:27+00:00 0.5 https://med.bayer.ca/Bayer_Consent_Request 2026-04-07T19:28:19+00:00 0.5 https://med.bayer.ca/fr/Demande_de_Consentement_Bayer 2026-04-07T19:28:19+00:00 0.5 https://med.bayer.ca/article/oceanic-stroke 2026-04-16T20:09:15+00:00 0.5 https://med.bayer.ca/404-page 2026-01-22T13:44:00+00:00 0.5 https://med.bayer.ca/fr/page-404 2026-01-22T13:44:00+00:00 0.5 https://med.bayer.ca/privacy-statement 2026-01-22T13:48:58+00:00 0.5 https://med.bayer.ca/fr/enonce-sur-la-confidentialite 2026-01-22T13:48:58+00:00 0.5 https://med.bayer.ca/test-table 2024-05-16T10:26:24+00:00 0.5 https://med.bayer.ca/test-search-en 2024-06-12T12:35:56+00:00 0.5 https://med.bayer.ca/fr/test-search-fr 2024-06-12T12:35:56+00:00 0.5 https://med.bayer.ca/register-login-further-access 2024-07-04T14:42:13+00:00 0.5 https://med.bayer.ca/fr/sinscrire-se-connecter-pour-plus-dacces 2024-07-04T14:42:13+00:00 0.5 https://med.bayer.ca/conditions-use 2026-01-22T13:48:32+00:00 0.5 https://med.bayer.ca/fr/conditions-dutilisation 2026-01-22T13:48:32+00:00 0.5 https://med.bayer.ca/imprint 2026-01-22T13:47:50+00:00 0.5 https://med.bayer.ca/fr/reference-de-publication 2026-01-22T13:47:50+00:00 0.5 https://med.bayer.ca/accessibility 2026-01-22T13:44:47+00:00 0.5 https://med.bayer.ca/fr/accessibilite 2026-01-22T13:44:47+00:00 0.5 https://med.bayer.ca/contact-us 2026-01-22T13:44:22+00:00 0.5 https://med.bayer.ca/fr/nous-joindre 2026-01-22T13:44:22+00:00 0.5 https://med.bayer.ca/test-page-en 2025-10-24T14:46:03+00:00 0.5 https://med.bayer.ca/fr/node/1931 2025-10-24T14:46:03+00:00 0.5 https://med.bayer.ca/oncology-home-page 2025-03-17T17:42:32+00:00 0.5 https://med.bayer.ca/fr/oncology-home-page-fr 2025-03-17T17:42:32+00:00 0.5 https://med.bayer.ca/cardio-renal-home-page 2025-03-17T17:42:26+00:00 0.5 https://med.bayer.ca/publications 2025-03-17T14:05:46+00:00 0.5 https://med.bayer.ca/ 2025-08-05T19:10:08+00:00 0.5 https://med.bayer.ca/fr 2025-08-05T19:10:08+00:00 0.5 https://med.bayer.ca/resource-library 2025-06-11T20:15:50+00:00 0.5 https://med.bayer.ca/cme 2025-03-17T13:00:38+00:00 0.5 https://med.bayer.ca/studies-and-guidelines 2025-03-17T17:42:40+00:00 0.5 https://med.bayer.ca/generic-home-page 2025-02-04T15:26:34+00:00 0.5 https://med.bayer.ca/cme-0 2025-03-17T17:42:18+00:00 0.5 https://med.bayer.ca/clinical-trials 2025-03-17T17:42:08+00:00 0.5 https://med.bayer.ca/congresses 2025-03-17T17:41:56+00:00 0.5 https://med.bayer.ca/heart-failure-medical-literature 2025-04-09T14:46:11+00:00 0.5 https://med.bayer.ca/medical-literature 2025-04-28T12:57:17+00:00 0.5 https://med.bayer.ca/test-hero 2025-10-01T06:29:28+00:00 0.5 https://med.bayer.ca/march-2026-cvr-calendar 2026-03-12T13:38:44+00:00 0.5 https://med.bayer.ca/april-2026-cvr-calendar 2026-03-12T13:39:40+00:00 0.5 https://med.bayer.ca/july-2026-cvr-calendar 2026-03-12T13:39:00+00:00 0.5 https://med.bayer.ca/listing_page/videos 2025-03-17T10:46:31+00:00 0.5 https://med.bayer.ca/fr/listing_page/videos 2025-03-17T10:46:31+00:00 0.5 https://med.bayer.ca/listing_page/asco-gu-2023 2025-03-17T17:44:54+00:00 0.5 https://med.bayer.ca/listing_page/cua-2023 2025-03-17T17:44:43+00:00 0.5 https://med.bayer.ca/listing_page/clinical-trials 2025-03-17T10:56:48+00:00 0.5 https://med.bayer.ca/listing_page/congresses 2025-03-17T11:15:40+00:00 0.5 https://med.bayer.ca/listing_page/infographics 2025-03-17T10:50:40+00:00 0.5 https://med.bayer.ca/listing_page/product-monographs 2025-03-17T10:51:28+00:00 0.5 https://med.bayer.ca/listing_page/external-resources 2025-03-17T10:48:06+00:00 0.5 https://med.bayer.ca/listing_page/mcrpc-cme 2025-03-17T17:44:50+00:00 0.5 https://med.bayer.ca/listing_page/nmcrpc-mcspc-cme 2025-03-17T13:02:25+00:00 0.5 https://med.bayer.ca/listing_page/medscape 2025-03-17T17:44:46+00:00 0.5 https://med.bayer.ca/listing_page/cme 2025-03-17T10:36:06+00:00 0.5 https://med.bayer.ca/listing_page/podcasts 2025-03-17T10:43:51+00:00 0.5 https://med.bayer.ca/listing_page/studies 2025-03-17T10:54:44+00:00 0.5 https://med.bayer.ca/listing_page/guidelines 2025-03-17T10:54:07+00:00 0.5 https://med.bayer.ca/listing_page/videos-0 2023-12-11T19:43:16+00:00 0.5 https://med.bayer.ca/listing_page/slide-decks 2025-03-17T10:40:45+00:00 0.5 https://med.bayer.ca/listing_page/aramis 2025-03-17T17:44:37+00:00 0.5 https://med.bayer.ca/listing_page/arasens 2025-03-17T17:44:40+00:00 0.5 https://med.bayer.ca/listing_page/other-learning-activities 2025-03-17T11:16:38+00:00 0.5 https://med.bayer.ca/media/multidisciplinary-care-best-practices-mcspc 2025-03-17T12:48:03+00:00 0.5 https://med.bayer.ca/fr/media/meilleures-pratiques-de-soins-multidisciplinaires-dans-le-cadre-du-cpscm-0 2025-03-17T12:48:03+00:00 0.5 https://med.bayer.ca/media/sequencing-strategies-advanced-prostate-cancer 2025-03-17T12:43:53+00:00 0.5 https://med.bayer.ca/fr/media/strategies-de-sequence-des-traitements-dans-le-cadre-du-cprcm-0 2025-03-17T12:43:53+00:00 0.5 https://med.bayer.ca/media/asco-2023-prostate-cancer-highlights 2025-03-17T12:40:05+00:00 0.5 https://med.bayer.ca/fr/media/asco-2023-points-importants-sur-le-cancer-de-la-prostate-par-les-drs-kollmannsberger-wallis 2025-03-17T12:40:05+00:00 0.5 https://med.bayer.ca/media/practical-use-finerenone 2025-03-18T07:02:46+00:00 0.5 https://med.bayer.ca/fr/media/utilisation-pratique-de-la-finerenone 2025-03-18T07:02:46+00:00 0.5 https://med.bayer.ca/media/american-diabetes-association-ada-and-kidney-disese-improving-global-outcomes-kdigo-consensus 2025-03-17T11:20:41+00:00 0.5 https://med.bayer.ca/fr/media/enonce-consensuel-de-2022-de-lamerican-diabetes-association-ada-et-de-kidney-disease 2025-03-17T11:20:41+00:00 0.5 https://med.bayer.ca/media/medical-discussion-topic-mdt-finerenone-and-chronic-kidney-disease-type-2-diabetes 2025-03-17T11:30:31+00:00 0.5 https://med.bayer.ca/fr/media/roles-des-recepteurs-des-mineralocorticoides-dans-la-progression-de-la-nephropathie-chronique 2025-03-17T11:30:31+00:00 0.5 https://med.bayer.ca/media/medical-discussion-topic-mdt-unmet-needs-and-early-diagnosis-chronic-kidney-disease-type-2 2025-03-18T07:01:25+00:00 0.5 https://med.bayer.ca/fr/media/besoins-non-combles-et-diagnostic-precoce-de-la-nephropathie-chronique-associee-au-diabete-de 2025-03-18T07:01:25+00:00 0.5 https://med.bayer.ca/media/confidence-randomised-controlled-trial 2025-03-17T11:22:22+00:00 0.5 https://med.bayer.ca/fr/media/confidence-une-etude-randomisee-controlee 2025-03-17T11:22:22+00:00 0.5 https://med.bayer.ca/media/fiona-study 2025-03-17T18:04:41+00:00 0.5 https://med.bayer.ca/fr/media/etude-fiona 2025-03-17T18:04:41+00:00 0.5 https://med.bayer.ca/media/real-life-cases-patients-t2d-and-ckd 2025-03-17T11:46:57+00:00 0.5 https://med.bayer.ca/fr/media/cas-reels-de-patients-atteints-de-diabete-de-type-2-et-de-nephropathie-chronique 2025-03-17T11:46:57+00:00 0.5 https://med.bayer.ca/media/patient-t2d-and-advanced-ckd-clinical-practice 2025-03-17T11:57:23+00:00 0.5 https://med.bayer.ca/fr/media/le-patient-atteint-de-diabete-de-type-2-et-de-nephropathie-chronique-avancee-dans-la-pratique 2025-03-17T11:57:23+00:00 0.5 https://med.bayer.ca/media/updates-clinical-use-non-steroidal-mineralocorticoid-receptor-antagonists-non-steroidal-mras 2025-03-17T12:25:12+00:00 0.5 https://med.bayer.ca/fr/media/mises-jour-sur-lutilisation-clinique-des-antagonistes-non-steroidiens-des-recepteurs-des 2025-03-17T12:25:12+00:00 0.5 https://med.bayer.ca/media/novel-treatment-options-ckd-t2d-evaluating-latest-landmark-trial-results 2025-03-17T11:40:10+00:00 0.5 https://med.bayer.ca/fr/media/nouvelles-options-therapeutiques-pour-le-traitement-de-la-nephropathie-chronique-chez-les 2025-03-17T11:40:10+00:00 0.5 https://med.bayer.ca/media/ckd-t2d-patient-selection-and-education-improved-outcomes 2025-03-17T11:41:54+00:00 0.5 https://med.bayer.ca/fr/media/nephropathie-chronique-associee-au-diabete-de-type-2-selection-et-education-des-patients-pour 2025-03-17T11:41:54+00:00 0.5 https://med.bayer.ca/media/updates-nsmra-review-data 2025-03-17T11:45:03+00:00 0.5 https://med.bayer.ca/fr/media/mises-jour-sur-les-antagonistes-non-steroidiens-des-recepteurs-des-mineralocorticoides-examen 2025-03-17T11:45:03+00:00 0.5 https://med.bayer.ca/media/screen-or-not-screen-kidney-disease 2025-03-17T11:43:11+00:00 0.5 https://med.bayer.ca/fr/media/depister-ou-ne-pas-depister-les-nephropathies 2025-03-17T11:43:11+00:00 0.5 https://med.bayer.ca/media/live-asco-gu-2023 2025-03-17T12:56:16+00:00 0.5 https://med.bayer.ca/fr/media/en-direct-depuis-lasco-gu-2023 2025-03-17T12:56:16+00:00 0.5 https://med.bayer.ca/media/asco-2023-prostate-cancer-highlights-0 2025-03-17T12:49:05+00:00 0.5 https://med.bayer.ca/fr/media/asco-2023-points-importants-sur-le-cancer-de-la-prostate-0 2025-03-17T12:49:05+00:00 0.5 https://med.bayer.ca/media/sequencing-strategies-mcrpc 2025-03-17T12:52:22+00:00 0.5 https://med.bayer.ca/fr/media/strategies-de-sequence-des-traitements-dans-le-cadre-du-cprcm 2025-03-17T12:52:22+00:00 0.5 https://med.bayer.ca/media/multidisciplinary-care-best-practices-mcspc-0 2025-03-17T12:50:41+00:00 0.5 https://med.bayer.ca/fr/media/meilleures-pratiques-de-soins-multidisciplinaires-dans-le-cadre-du-cpscm 2025-03-17T12:50:41+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-vid-1-welcome-dr-aly-khan-lalani 2025-03-17T18:09:12+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-video-1-accueil-par-le-dr-aly-khan-lalani 2025-03-17T18:09:12+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-arasens-peace-i-dr-aly-khan-lalani 2025-03-17T18:15:54+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-arasens-et-peace-i-dr-aly-khan-lalani 2025-03-17T18:15:54+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-arasens-peace-i-francais-dr-vincent-fradet 2025-03-17T18:16:40+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-arasens-et-peace-i-francais-dr-vincent-fradet 2025-03-17T18:16:40+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-propel-dr-michael-kolinsky 2025-03-17T18:17:26+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-propel-dr-michael-kolinsky 2025-03-17T18:17:26+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-pace-dr-andrew-loblaw 2025-03-17T12:54:26+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-pace-dr-andrew-loblaw 2025-03-17T12:54:26+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-talapro-2-dr-ramy-saleh 2025-03-17T18:08:58+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-talapro-2-dr-ramy-saleh 2025-03-17T18:08:58+00:00 0.5 https://med.bayer.ca/media/dr-bobby-shayegan-cua-highlights 2025-03-17T18:08:54+00:00 0.5 https://med.bayer.ca/fr/media/dr-bobby-shayegan-auc-points-importants 2025-03-17T18:08:54+00:00 0.5 https://med.bayer.ca/media/dr-safiya-karim-cua-highlights 2025-03-17T18:08:51+00:00 0.5 https://med.bayer.ca/fr/media/dre-safiya-karim-auc-points-importants 2025-03-17T18:08:51+00:00 0.5 https://med.bayer.ca/media/mcspc-disease-landscape-overview 2025-03-17T12:28:13+00:00 0.5 https://med.bayer.ca/fr/media/cpscm-apercu-de-la-maladie-et-du-paysage-therapeutique 2025-03-17T12:28:13+00:00 0.5 https://med.bayer.ca/media/darolutamide-mcspc-arasens-study 2025-03-17T12:26:37+00:00 0.5 https://med.bayer.ca/fr/media/darolutamide-dans-le-traitement-du-cpscm-etude-arasens 2025-03-17T12:26:37+00:00 0.5 https://med.bayer.ca/media/darolutamide-nmcrpc-aramis-study 2025-03-17T12:32:52+00:00 0.5 https://med.bayer.ca/fr/media/darolutamide-dans-le-cprcnm-etude-aramis 2025-03-17T12:32:52+00:00 0.5 https://med.bayer.ca/media/nmcrpc-disease-landscape-overview 2025-03-17T12:38:09+00:00 0.5 https://med.bayer.ca/fr/media/cprcnm-apercu-de-la-maladie-et-du-paysage-therapeutique 2025-03-17T12:38:09+00:00 0.5 https://med.bayer.ca/media/darolutamide-real-world-evidence-nmcrpc 2025-03-17T12:36:19+00:00 0.5 https://med.bayer.ca/fr/media/donnees-probantes-en-situation-reelle-sur-le-darolutamide-dans-le-contexte-du-cprcnm 2025-03-17T12:36:19+00:00 0.5 https://med.bayer.ca/media/arat-drug-drug-interactions 2025-03-17T12:29:31+00:00 0.5 https://med.bayer.ca/fr/media/interactions-medicamenteuses-avec-les-arat 2025-03-17T12:29:31+00:00 0.5 https://med.bayer.ca/media/procure 2025-03-17T12:58:54+00:00 0.5 https://med.bayer.ca/fr/media/procure 2025-03-17T12:58:54+00:00 0.5 https://med.bayer.ca/media/cua 2025-03-17T12:57:37+00:00 0.5 https://med.bayer.ca/fr/media/auc 2025-03-17T12:57:37+00:00 0.5 https://med.bayer.ca/media/clinical-advances-advanced-prostate-cancer 2025-03-17T13:05:58+00:00 0.5 https://med.bayer.ca/fr/media/avancees-cliniques-dans-le-cancer-avance-de-la-prostate 2025-03-17T13:05:58+00:00 0.5 https://med.bayer.ca/media/optimizing-outcomes-patients-metastatic-hormone-sensitive-prostate-cancer 2025-03-17T13:15:40+00:00 0.5 https://med.bayer.ca/fr/media/optimiser-les-resultats-chez-les-patients-atteints-dun-cancer-de-la-prostate-metastatique 2025-03-17T13:15:40+00:00 0.5 https://med.bayer.ca/media/interprofessional-clinic-team-based-approach-oral-therapies-prostate-cancer 2025-03-17T13:09:16+00:00 0.5 https://med.bayer.ca/fr/media/clinique-interprofessionnelle-une-approche-en-equipe-des-therapies-orales-dans-le-cancer-de 2025-03-17T13:09:16+00:00 0.5 https://med.bayer.ca/media/which-mcspc-patients-benefit-early-treatment-intensification 2025-03-17T13:18:38+00:00 0.5 https://med.bayer.ca/fr/media/quels-sont-les-patients-atteints-de-cpscm-qui-beneficient-dune-intensification-precoce-du 2025-03-17T13:18:38+00:00 0.5 https://med.bayer.ca/media/role-nurse-nmcrpc-patient-management 2025-03-17T13:17:16+00:00 0.5 https://med.bayer.ca/fr/media/le-role-du-personnel-infirmier-dans-la-prise-en-charge-des-patients-atteints-de-cprcnm 2025-03-17T13:17:16+00:00 0.5 https://med.bayer.ca/media/exploring-perspectives-clinical-cases-mcspc-nmcrpc-peervoice 2025-03-17T13:07:56+00:00 0.5 https://med.bayer.ca/fr/media/explorer-les-perspectives-sur-des-cas-cliniques-de-cpscm-et-de-cprcnm 2025-03-17T13:07:56+00:00 0.5 https://med.bayer.ca/media/clinical-conversation-mcspc-intensifying-therapy-earlier-disease-course 2025-03-17T13:21:10+00:00 0.5 https://med.bayer.ca/fr/media/conversation-clinique-sur-le-cancer-de-la-prostate-metastatique-hormonosensible-intensifier 2025-03-17T13:21:10+00:00 0.5 https://med.bayer.ca/media/contemporary-management-prostate-cancer-updated-approaches-improved-outcomes-nmcrpc-and-mcspc 2025-03-17T13:03:38+00:00 0.5 https://med.bayer.ca/fr/media/prise-en-charge-actuelle-du-cancer-de-la-prostate-nouvelles-approches-pour-lamelioration-des 2025-03-17T13:03:38+00:00 0.5 https://med.bayer.ca/media/integrating-data-practice-assessing-latest-prostate-data-2023-spring-and-summer-oncology 2025-03-17T13:04:39+00:00 0.5 https://med.bayer.ca/fr/media/integrer-les-donnees-dans-la-pratique-evaluation-des-dernieres-donnees-sur-la-prostate-issues 2025-03-17T13:04:39+00:00 0.5 https://med.bayer.ca/media/sequencing-radioligands-therapies-mcrpc 2025-03-17T13:24:11+00:00 0.5 https://med.bayer.ca/fr/media/strategies-de-sequence-des-traitements-par-radioligands-dans-le-cadre-du-cancer-de-la 2025-03-17T13:24:11+00:00 0.5 https://med.bayer.ca/media/radiopharmaceuticals-mcrpc 2025-03-17T13:22:24+00:00 0.5 https://med.bayer.ca/fr/media/produits-radiopharmaceutiques-dans-le-traitement-du-cancer-de-la-prostate-metastatique 2025-03-17T13:22:24+00:00 0.5 https://med.bayer.ca/media/evolving-role-radiopharmaceuticals-mcrpc 2025-03-17T13:25:33+00:00 0.5 https://med.bayer.ca/fr/media/levolution-du-role-des-produits-radiopharmaceutiques-dans-le-cadre-du-cprcm 2025-03-17T13:25:33+00:00 0.5 https://med.bayer.ca/media/arasens 2025-03-17T18:06:17+00:00 0.5 https://med.bayer.ca/fr/media/arasens 2025-03-17T18:06:17+00:00 0.5 https://med.bayer.ca/media/arasens-volume-risk-subgroups-analysis 2025-03-18T08:08:27+00:00 0.5 https://med.bayer.ca/fr/media/arasens-analyse-des-sous-groupes-bases-sur-le-volume-et-le-risque 2025-03-18T08:08:27+00:00 0.5 https://med.bayer.ca/media/aramis 2025-03-18T08:07:04+00:00 0.5 https://med.bayer.ca/fr/media/aramis 2025-03-18T08:07:04+00:00 0.5 https://med.bayer.ca/media/aramis-spanish-subgroup-analysis 2025-03-18T08:06:04+00:00 0.5 https://med.bayer.ca/fr/media/aramis-analyse-du-sous-groupe-de-patients-espagnols 2025-03-18T08:06:04+00:00 0.5 https://med.bayer.ca/media/aramis-psadt-subgroup-analysis 2025-03-18T08:04:50+00:00 0.5 https://med.bayer.ca/fr/media/aramis-analyse-du-sous-groupe-stratifie-en-fonction-du-tdaps 2025-03-18T08:04:50+00:00 0.5 https://med.bayer.ca/media/aramis-japanese-subgroup-analysis 2025-03-17T18:05:59+00:00 0.5 https://med.bayer.ca/fr/media/aramis-analyse-du-sous-groupe-de-patients-japonais 2025-03-17T18:05:59+00:00 0.5 https://med.bayer.ca/media/aramis-blackafrican-american-subgroup-analysis 2025-03-18T08:03:47+00:00 0.5 https://med.bayer.ca/fr/media/aramis-analyse-de-sous-groupe-de-patients-noirsafro-americains 2025-03-18T08:03:47+00:00 0.5 https://med.bayer.ca/media/cua-2022-castration-resistant-prostate-cancer-guidelines 2025-03-17T18:18:09+00:00 0.5 https://med.bayer.ca/fr/media/lignes-directrices-de-lauc-sur-le-cancer-de-la-prostate-resistant-la-castration-2022 2025-03-17T18:18:09+00:00 0.5 https://med.bayer.ca/media/cua-2022-metastatic-castration-naive-and-castration-sensitive-prostate-cancer-guidelines 2025-03-17T18:19:11+00:00 0.5 https://med.bayer.ca/fr/media/lignes-directrices-de-lauc-2022-sur-le-cancer-de-la-prostate-nayant-pas-fait-lobjet-dun 2025-03-17T18:19:11+00:00 0.5 https://med.bayer.ca/media/nccn-prostate-cancer-guidelines 2025-03-17T18:20:06+00:00 0.5 https://med.bayer.ca/fr/media/lignes-directrices-du-nccn 2025-03-17T18:20:06+00:00 0.5 https://med.bayer.ca/media/aua-prostate-cancer-guidelines 2025-03-17T13:27:47+00:00 0.5 https://med.bayer.ca/fr/media/lignes-directrices-de-laua-sur-le-cancer-de-la-prostate 2025-03-17T13:27:47+00:00 0.5 https://med.bayer.ca/media/asco-genitourinary-cancer-guidelines 2025-03-17T13:26:21+00:00 0.5 https://med.bayer.ca/fr/media/lignes-directrices-de-lasco-sur-le-cancer-genito-urinaire 2025-03-17T13:26:21+00:00 0.5 https://med.bayer.ca/media/arastep 2025-03-18T07:40:09+00:00 0.5 https://med.bayer.ca/fr/media/arastep 2025-03-18T07:40:09+00:00 0.5 https://med.bayer.ca/media/darol 2025-03-18T08:00:21+00:00 0.5 https://med.bayer.ca/fr/media/darol 2025-03-18T08:00:21+00:00 0.5 https://med.bayer.ca/media/aranote 2025-03-18T07:42:23+00:00 0.5 https://med.bayer.ca/fr/media/aranote 2025-03-18T07:42:23+00:00 0.5 https://med.bayer.ca/media/dasl-hicap 2025-03-17T18:06:31+00:00 0.5 https://med.bayer.ca/fr/media/dasl-hicap 2025-03-17T18:06:31+00:00 0.5 https://med.bayer.ca/media/oncology-pipeline 2025-03-18T07:12:01+00:00 0.5 https://med.bayer.ca/fr/media/portefeuille-de-produits-en-oncologie 2025-03-18T07:12:01+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023 2025-03-17T13:39:30+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023 2025-03-17T13:39:30+00:00 0.5 https://med.bayer.ca/media/eau-2023 2025-03-17T13:42:52+00:00 0.5 https://med.bayer.ca/fr/media/eau-2023 2025-03-17T13:42:52+00:00 0.5 https://med.bayer.ca/media/aua-2023 2025-03-17T13:41:18+00:00 0.5 https://med.bayer.ca/fr/media/aua-2023 2025-03-17T13:41:18+00:00 0.5 https://med.bayer.ca/media/aacr-2023 2025-03-17T13:29:09+00:00 0.5 https://med.bayer.ca/fr/media/aacr-2023 2025-03-17T13:29:09+00:00 0.5 https://med.bayer.ca/media/asco-2023 2025-03-17T13:30:12+00:00 0.5 https://med.bayer.ca/fr/media/asco-2023 2025-03-17T13:30:12+00:00 0.5 https://med.bayer.ca/media/darolutamide-psa-responses 2025-03-17T12:34:29+00:00 0.5 https://med.bayer.ca/fr/media/reponses-de-laps-au-darolutamide 2025-03-17T12:34:29+00:00 0.5 https://med.bayer.ca/media/kidney-failure-risk-equation 2025-03-17T18:08:12+00:00 0.5 https://med.bayer.ca/fr/media/kidney-failure-risk-equation 2025-03-17T18:08:12+00:00 0.5 https://med.bayer.ca/media/asco-2023-prostate-cancer-highlights-1 2025-03-17T12:42:20+00:00 0.5 https://med.bayer.ca/fr/media/asco-2023-points-importants-sur-le-cancer-de-la-prostate 2025-03-17T12:42:20+00:00 0.5 https://med.bayer.ca/media/asco-gu-2023-prostate-cancer-highlights 2025-03-17T12:31:23+00:00 0.5 https://med.bayer.ca/fr/media/asco-gu-2023-points-importants-sur-le-cancer-de-la-prostate 2025-03-17T12:31:23+00:00 0.5 https://med.bayer.ca/media/product-monograph-finerenone 2025-03-17T18:08:15+00:00 0.5 https://med.bayer.ca/fr/media/monographie-de-la-finerenone 2025-03-17T18:08:15+00:00 0.5 https://med.bayer.ca/media/product-monograph-darolutamide 2025-03-17T18:06:33+00:00 0.5 https://med.bayer.ca/fr/media/monographies-de-produits 2025-03-17T18:06:33+00:00 0.5 https://med.bayer.ca/media/apex-iud-study 2025-03-17T18:20:58+00:00 0.5 https://med.bayer.ca/fr/media/etude-apex-iud 2025-03-17T18:20:58+00:00 0.5 https://med.bayer.ca/media/contraceptive-efficacy-mirena-8-years 2025-03-17T18:06:38+00:00 0.5 https://med.bayer.ca/fr/media/efficacite-contraceptive-de-mirena-jusqua-8-ans 2025-03-17T18:06:38+00:00 0.5 https://med.bayer.ca/media/tvasurg-larc-insertion-video 2025-03-17T18:06:27+00:00 0.5 https://med.bayer.ca/fr/media/tvasurg-video-sur-linsertion-dune-mcrap 2025-03-17T18:06:27+00:00 0.5 https://med.bayer.ca/media/cost-unintended-pregnancies-universal-contraceptive-coverage-canada-highlights 2025-03-17T18:06:50+00:00 0.5 https://med.bayer.ca/fr/media/points-importants-sur-le-cout-des-grossesses-non-planifiees-et-la-couverture-universelle-de 2025-03-17T18:06:50+00:00 0.5 https://med.bayer.ca/media/intrauterine-device-iud-insertion-and-removal 2025-03-17T18:06:47+00:00 0.5 https://med.bayer.ca/fr/media/insertion-et-retrait-des-dispositifs-intra-uterins-diu 2025-03-17T18:06:47+00:00 0.5 https://med.bayer.ca/media/improving-patient-counselling-contraceptive-treatment 2025-03-18T08:00:48+00:00 0.5 https://med.bayer.ca/fr/media/amelioration-des-conseils-prodigues-aux-patientes-sur-les-traitements-contraceptifs 2025-03-18T08:00:48+00:00 0.5 https://med.bayer.ca/media/findings-mirena-extension-trial-slide-deck 2025-03-17T18:06:41+00:00 0.5 https://med.bayer.ca/fr/media/diaporama-sur-les-conclusions-de-letude-mirena-extension-trial 2025-03-17T18:06:41+00:00 0.5 https://med.bayer.ca/media/overview-intrauterine-contraception-healthcare-providers 2025-03-17T18:08:06+00:00 0.5 https://med.bayer.ca/fr/media/vue-densemble-de-la-contraception-intra-uterine-destinee-aux-professionnels-de-la-sante 2025-03-17T18:08:06+00:00 0.5 https://med.bayer.ca/media/bayer-x-virtamed-online-ius-insertion-training 2025-03-17T18:04:18+00:00 0.5 https://med.bayer.ca/fr/media/bayer-x-virtamed-formation-en-ligne-sur-linsertion-des-siu 2025-03-17T18:04:18+00:00 0.5 https://med.bayer.ca/media/kyleena-satisfaction-study-highlights 2025-03-17T18:06:44+00:00 0.5 https://med.bayer.ca/fr/media/points-importants-de-letude-sur-la-satisfaction-legard-de-kyleena 2025-03-17T18:06:44+00:00 0.5 https://med.bayer.ca/media/product-monograph-mirena 2025-07-16T20:01:43+00:00 0.5 https://med.bayer.ca/fr/media/monographie-de-produit-de-mirena 2025-07-16T20:01:43+00:00 0.5 https://med.bayer.ca/media/product-monograph-kyleena 2026-01-23T14:56:17+00:00 0.5 https://med.bayer.ca/fr/media/monographie-de-produit-de-kyleena 2026-01-23T14:56:17+00:00 0.5 https://med.bayer.ca/media/english-media-test 2025-03-17T18:09:30+00:00 0.5 https://med.bayer.ca/fr/media/test-des-medias-francais 2025-03-17T18:09:30+00:00 0.5 https://med.bayer.ca/media/figaro-bm-unpublish 2025-07-31T08:17:00+00:00 0.5 https://med.bayer.ca/media/practical-use-finerenone-unpublish 2025-07-31T13:47:10+00:00 0.5 https://med.bayer.ca/media/product-monograph-finerenone-0 2025-07-11T13:45:27+00:00 0.5 https://med.bayer.ca/media/confidence-core-deck 2025-08-01T12:31:00+00:00 0.5 https://med.bayer.ca/fr/media/diaporama-principal-sur-letude-confidence 2025-08-01T12:31:00+00:00 0.5 https://med.bayer.ca/media/foundation-rwe 2025-07-25T16:58:38+00:00 0.5 https://med.bayer.ca/fr/media/foundation-dsr 2025-07-25T16:58:38+00:00 0.5 https://med.bayer.ca/media/symphony-two-movements 2025-07-14T17:44:16+00:00 0.5 https://med.bayer.ca/media/cooling-chaos-ola-deck 2025-07-17T19:00:20+00:00 0.5 https://med.bayer.ca/media/arasens-primary-publication 2025-10-02T15:31:55+00:00 0.5 https://med.bayer.ca/media/oceanic-stroke-study-overview 2026-04-16T20:02:59+00:00 0.5 https://med.bayer.ca/media/oceanic-stroke-primary-results 2026-04-20T20:16:17+00:00 0.5 https://med.bayer.ca/take-action-womens-health/access-three-series-learning-programs-regarding-intrauterine-contraception 2025-03-17T18:02:24+00:00 0.5 https://med.bayer.ca/take-action-womens-health/optimizing-patient-experience-during-iuc-insertion 2025-03-17T18:02:31+00:00 0.5 https://med.bayer.ca/take-action-womens-health/managing-heavy-menstrual-bleeding 2025-03-17T18:02:37+00:00 0.5 https://med.bayer.ca/take-action-womens-health/addressing-patients-common-concerns-iuds-during-contraceptive-counselling 2025-03-17T18:02:39+00:00 0.5 https://med.bayer.ca/take-action-womens-health/addressing-patients-complex-concerns-iuds-during-contraceptive-counselling 2025-03-17T18:02:43+00:00 0.5 https://med.bayer.ca/take-action-womens-health/counselling-iuc 2025-03-17T18:02:33+00:00 0.5 https://med.bayer.ca/contraception/contraception 2025-04-25T14:35:00+00:00 0.5 https://med.bayer.ca/menopause/unused 2025-06-03T12:53:23+00:00 0.5 https://med.bayer.ca/fr/menopause/unused-fr 2025-06-03T12:53:23+00:00 0.5 https://med.bayer.ca/take-action-womens-health/xtake-action-womens-health 2025-06-20T14:02:01+00:00 0.5